Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotrophic lateral sclerosis
-
AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19
-
Update on US regulatory review of roxadustat in anaemia of chronic kidney disease
-
Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes
-
Enhertu significantly improved progression-free survival in DESTINY-Breast03 head-to-head trial vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
-
Saphnelo (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus
-
H1 2021 results
-
Vaxzevria and mRNA COVID-19 vaccines showed similar and favourable safety profiles in a population-based cohort study of over a million people
-
Vaxzevria showed no increased incidence of thrombosis with thrombocytopenia after second dose
-
AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
Latest articles and press releases
All of our latest press releases and articles are available to explore
